These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11874208

  • 1. An endogenous Na+, K+-ATPase inhibitor enhances phosphoinositide hydrolysis in neonatal but not in adult rat brain cortex.
    Calviño MA, Peña C, Rodríguez de Lores Arnaiz G.
    Neurochem Res; 2001 Nov; 26(11):1253-9. PubMed ID: 11874208
    [Abstract] [Full Text] [Related]

  • 2. Metabotropic glutamate receptor involvement in phosphoinositide hydrolysis stimulation by an endogenous Na(+), K(+)-ATPase inhibitor and ouabain in neonatal rat brain.
    Calviño MA, Peña C, Rodríguez de Lores Arnaiz G.
    Brain Res Dev Brain Res; 2002 Oct 20; 138(2):167-75. PubMed ID: 12354644
    [Abstract] [Full Text] [Related]

  • 3. High-affinity neurotensin receptor is involved in phosphoinositide turnover increase by inhibition of sodium pump in neonatal rat brain.
    Pereyra-Alfonso S, Del Valle Armanino M, Vázquez C, Peña C, Rodríguez de Lores Arnaiz G.
    Neurochem Res; 2008 Nov 20; 33(11):2206-13. PubMed ID: 18758956
    [Abstract] [Full Text] [Related]

  • 4. A brain Na+, K+-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus.
    Vatta M, Peña C, Fernández B, Rodríguez de Lores Arnaiz G.
    Neuroscience; 1999 May 20; 90(2):573-9. PubMed ID: 10215160
    [Abstract] [Full Text] [Related]

  • 5. Na+,K+-ATPase interaction with a brain endogenous inhibitor (endobain E).
    Rodríguez de Lores Arnaiz G, Reinés A, Herbin T, Peña C.
    Neurochem Int; 1998 Nov 20; 33(5):425-33. PubMed ID: 9874093
    [Abstract] [Full Text] [Related]

  • 6. Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.
    Bersier MG, Miksztowicz V, Peña C, Rodríguez de Lores Arnaiz G.
    Neurochem Res; 2005 Apr 20; 30(4):479-86. PubMed ID: 16076019
    [Abstract] [Full Text] [Related]

  • 7. [3H]dizocilpine binding to N-methyl-D-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain.
    Reinés A, Peña C, Rodríguez de Lores Arnaiz G.
    Neurochem Int; 2001 Oct 20; 39(4):301-10. PubMed ID: 11551670
    [Abstract] [Full Text] [Related]

  • 8. Allosteric modulation of [3H]dizocilpine binding to N-methyl-D-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation.
    Reinés A, Peña C, Rodríguez de Lores Arnaiz G.
    Brain Res; 2004 Jan 16; 996(1):117-25. PubMed ID: 14670638
    [Abstract] [Full Text] [Related]

  • 9. Characterization of ouabain-induced phosphoinositide hydrolysis in brain slices of the neonatal rat.
    Balduini W, Costa LG.
    Neurochem Res; 1990 Oct 16; 15(10):1023-9. PubMed ID: 1963925
    [Abstract] [Full Text] [Related]

  • 10. Endobain E, a brain Na+, K+ -ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus.
    Vatta M, Peña C, Fernández BE, Rodríguez de Lores Arnaiz G.
    Life Sci; 2004 Dec 10; 76(4):359-65. PubMed ID: 15530498
    [Abstract] [Full Text] [Related]

  • 11. Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions.
    Reinés A, Zárate S, Carmona C, Negri G, Peña C, Rodríguez de Lores Arnaiz G.
    Life Sci; 2005 Dec 05; 78(3):245-52. PubMed ID: 16107263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.
    Bersier MG, Peña C, Rodríguez de Lores Arnaiz G.
    Neurochem Res; 2008 Jan 05; 33(1):66-72. PubMed ID: 17680361
    [Abstract] [Full Text] [Related]

  • 14. The Na+, K(+)-ATPase inhibitor ouabain and the Na+ ionophore monensin have opposite effects upon carbachol-stimulated inositol phospholipid breakdown in rat cerebral cortical miniprisms.
    Tiger G, Fowler CJ.
    Cell Signal; 1991 Jan 05; 3(3):209-13. PubMed ID: 1654070
    [Abstract] [Full Text] [Related]

  • 15. The effect of an endogenous Na+, K+-ATPase inhibitor on rat lens transparency and ultrastructure.
    Pellegrino de Iraldi A, Peña C, Rodríguez de Lores Arnaiz G.
    Cell Mol Neurobiol; 2003 Apr 05; 23(2):131-41. PubMed ID: 12735627
    [Abstract] [Full Text] [Related]

  • 16. Changes in Na+, K+-ATPase activity and alpha 3 subunit expression in CNS after administration of Na+, K+-ATPase inhibitors.
    Bersier MG, Peña C, Arnaiz GR.
    Neurochem Res; 2011 Feb 05; 36(2):297-303. PubMed ID: 21080065
    [Abstract] [Full Text] [Related]

  • 17. Amiloride and amiloride analogs inhibit Na+/K+-transporting ATPase and Na+-coupled alanine transport in rat hepatocytes.
    Renner EL, Lake JR, Cragoe EJ, Scharschmidt BF.
    Biochim Biophys Acta; 1988 Mar 03; 938(3):386-94. PubMed ID: 2450581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phosphoinositide hydrolysis induced by depolarization and sodium channel activation in mouse cerebrocortical slices.
    Benuck M, Reith ME, Lajtha A.
    Neuropharmacology; 1989 Aug 03; 28(8):847-54. PubMed ID: 2550841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.